A final-stage clinical trial comparing a new long-acting, once-weekly pill to treat schizophrenia symptoms with the existing daily treatment has found that both produce comparable therapeutic effects.

A weekly oral risperidone capsule has shown promising results in schizophrenia treatment, maintaining stable drug levels, ...

The FDA has approved a new pill called Widaplik, which combines three drugs – telmisartan, amlodipine, and indapamide – to treat adults who have high blood pressure.

For many patients with schizophrenia, other psychiatric illnesses, or diseases such as hypertension and asthma, it can be ...

For many patients with schizophrenia, other psychiatric illnesses, or diseases such as hypertension and asthma, it can be ...

The U.S. Food and Drug Administration has paused Gilead Sciences' trials testing a combination of two of its experimental HIV ...